NOTCH1 and cancer: According to the study of Schwaederle et al. (26), the most frequent alterations among diverse cancers were reported to be TP53 (29.8%), followed, respectively, by EGFR (17.5%), MET (10.5%), PIK3CA (7%), and NOTCH1 (5.8%).